Connor, Clark & Lunn Investment Management (CC&L)’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-15,710	Closed	-$165K	–	987
2016 Q1	$165K	Sell	15,710 -3,960	-20%	-$41.6K	﹤0.01%	729
2015 Q4	$580K	Buy	19,670 +5,495	+39%	+$162K	﹤0.01%	523
2015 Q3	$448K	Buy	14,175 +10,210	+258%	+$323K	﹤0.01%	541
2015 Q2	$235K	Buy	+3,965	New	+$235K	﹤0.01%	534